Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Willson
S Lawrence

Showing results (1271-1280 of 1,504) with videos related to

Pageof 151
Sort By:
Cancer Research|December 8, 2016
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH BiosynthesisDaniel R Wahl, Joseph Dresser, Kari Wilder-Romans, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2007
The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancerLujun Zhao, Kerby Sheldon, Ming Chen, et al.
ACS Infectious Diseases|February 27, 2025
Teixobactin: A Resistance-Evading Antibiotic for Treating AnthraxWilliam S Lawrence, Jennifer E Peel, Rosan de Winter, et al.
Sleep|December 11, 2021
Combined intermittent and sustained hypoxia is a novel and deleterious cardio-metabolic phenotypeXin Zhen, Esteban A Moya, Mary Gautane, et al.
American Journal of Preventive Medicine|May 12, 2000
Developing the Guide to Community Preventive Services--overview and rationale. The Task Force on Community Preventive ServicesB I Truman, C K Smith-Akin, A R Hinman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 21, 2017
Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung CancerYilun Sun, Peter G Hawkins, Nan Bi, et al.
JAMA Oncology|June 2, 2017
Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical TrialFeng-Ming Kong, Randall K Ten Haken, Matthew Schipper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2023
A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular CarcinomaDaniel J Herr, Chang Wang, Mishal Mendiratta-Lala, et al.
Blood Advances|September 3, 2021
Storage temperature determines platelet GPVI levels and function in mice and humansJeffrey Miles, S Lawrence Bailey, Ava M Obenaus, et al.
NPJ Breast Cancer|August 26, 2017
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancerCorey Speers, Shuang G Zhao, Ben Chandler, et al.
Pageof 151

Showing results (1271-1280 of 1,504) with videos related to

Sort By:
Pageof 151
Cancer Research|December 8, 2016
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH BiosynthesisDaniel R Wahl, Joseph Dresser, Kari Wilder-Romans, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2007
The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancerLujun Zhao, Kerby Sheldon, Ming Chen, et al.
ACS Infectious Diseases|February 27, 2025
Teixobactin: A Resistance-Evading Antibiotic for Treating AnthraxWilliam S Lawrence, Jennifer E Peel, Rosan de Winter, et al.
Sleep|December 11, 2021
Combined intermittent and sustained hypoxia is a novel and deleterious cardio-metabolic phenotypeXin Zhen, Esteban A Moya, Mary Gautane, et al.
American Journal of Preventive Medicine|May 12, 2000
Developing the Guide to Community Preventive Services--overview and rationale. The Task Force on Community Preventive ServicesB I Truman, C K Smith-Akin, A R Hinman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 21, 2017
Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung CancerYilun Sun, Peter G Hawkins, Nan Bi, et al.
JAMA Oncology|June 2, 2017
Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical TrialFeng-Ming Kong, Randall K Ten Haken, Matthew Schipper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2023
A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular CarcinomaDaniel J Herr, Chang Wang, Mishal Mendiratta-Lala, et al.
Blood Advances|September 3, 2021
Storage temperature determines platelet GPVI levels and function in mice and humansJeffrey Miles, S Lawrence Bailey, Ava M Obenaus, et al.
NPJ Breast Cancer|August 26, 2017
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancerCorey Speers, Shuang G Zhao, Ben Chandler, et al.
Pageof 151